THIRD HARMONIC BIO INC's ticker is and the CUSIP is 88427A107. A total of 57 filers reported holding THIRD HARMONIC BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 10,907,859 | $69,701,219 | 10.80% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $11,502,000 | 1.62% |
| COMMODORE CAPITAL LP | 1,700,000 | $10,863,000 | 1.27% |
| Orbimed Advisors | 5,779,071 | $36,928,264 | 0.78% |
| BVF INC/IL | 4,365,933 | $27,898,312 | 0.75% |
| EcoR1 Capital, LLC | 2,982,444 | $19,057,817 | 0.64% |
| DAFNA Capital Management LLC | 300,000 | $1,917,000 | 0.60% |
| BRAIDWELL LP | 1,653,991 | $10,569,002 | 0.33% |
| GENERAL ATLANTIC, L.P. | 2,958,762 | $18,906,489 | 0.29% |
| Boxer Capital, LLC | 520,417 | $3,325,465 | 0.18% |
| Atika Capital Management LLC | 203,199 | $1,298,442 | 0.17% |
| RA Capital Management | 961,863 | $6,146,305 | 0.12% |
| UBS OCONNOR LLC | 125,000 | $798,750 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 89,100 | $569,349 | 0.01% |
| Annapolis Financial Services, LLC | 5,000 | $31,950 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 16,397 | $104,777 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 192,027 | $1,227,053 | 0.00% |
| MetLife Investment Management, LLC | 11,604 | $74,150 | 0.00% |
| Covestor Ltd | 207 | $1 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 33,428 | $213,605 | 0.00% |
This page lists THIRD HARMONIC BIO INC's shareholders in Q3 2023. To view THIRD HARMONIC BIO INC's shareholder history, click here.